New York State Common Retirement Fund Vincerx Pharma, Inc. Transaction History

New York State Common Retirement Fund

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 04, 2022	SELL	$0.0 - $0.0 $0 - $0	-4,700 Reduced 96.85%	153 $0
Q1 2022 May 05, 2022	BUY	$0.0 - $0.0 $0 - $0	42 Added 0.87%	4,853 $19,000
Q4 2021 Feb 02, 2022	BUY	$0.0 - $0.0 $0 - $0	65 Added 1.37%	4,811 $49,000
Q3 2021 Nov 02, 2021	SELL	$0.0 - $0.0 $0 - $0	-4,154 Reduced 46.67%	4,746 $77,000
Q2 2021 Aug 02, 2021	BUY	$0.0 - $27.0 $0 - $240,300	8,900 New	8,900 $116,000

11M

Ticker VINC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 21,189,800
Market Cap $6.57M
Description
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops therapies to address unmet medical needs for the treatment of cancer in the United States. Its lead product candidate is VIP152, a cyclin-dependent kinase-9 inhibitor for treating patients with advanced cancer. The company's preclinical stage product candid...

Get notified when there are updates to the investment portfolio of New York State Common Retirement Fund, based on Form 13F filings with the SEC.

Stay updated on New York State Common Retirement Fund with notifications on news.